The patient was admitted and started on broad spectrum antibiotics, and her pleural effusion was tapped.
The patient was loaded on Dilantin and, over the next several days, her neurological status was noticed to be slowly improving.
She required multiple packed red blood cell transfusions.
The patient eventually underwent a VATS with decortication in the Operating Room.
The patient, from that point on, was saturating well on two liters of oxygen by nasal cannula and was felt stable enough to be transferred to the floor.
At the point of transfer, the patient was still on antibiotics that were started in the Unit.
Syndrome of inappropriate diuretic hormone, on fluid restriction.
MEDICATIONS ON ADMISSION:  Home medications include Diovan, Norvasc, E-Vista, Levoxyl and hydralazine along with multivitamins; at the time of transfer, the patient was on levofloxacin 500 mg p.o.q.d., day 15 at time of transfer, Synthroid 88 mcg p.o.q.d., Colace 100 mg p.o.b.i.d., lansoprazole 30 mg p.o.q.d., fentanyl patch 25 mcg, Norvasc 2.5 mg p.o.q.d., albuterol nebulizer, cefepime, and vancomycin.
PHYSICAL EXAMINATION:  On physical examination, the patient had a temperature of 98.2, heart rate 70, respiratory rate 25, blood pressure 133/38 and oxygen saturation 96% on two liters nasal cannula.
LABORATORY DATA:  White blood cell count 13, hematocrit 31.3, platelet count 547,000, differential with 88% neutrophils and 4% bands, sodium 133, potassium 3.7, chloride 92, bicarbonate 32, creatinine 0.8, glucose 147, phenytoin level 2.1.
The patient was hydrated cautiously with intravenous fluids.
Nutrition was given via tube feeds via a nasogastric tube.
The patient's thyroid medication was increased.
The patient was consistently subtherapeutic with her Dilantin levels.
Dilantin was considered a possible culprit for causing hepatotoxicity as well as decreased mental status, and was discontinued.
She failed these and, prior to discharge, a gastrostomy tube was placed.
